Stock RDNT RADNET, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials RadNet, Inc.

Equities

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
48.4 USD -0.92% Intraday chart for RadNet, Inc. +4.04% +39.20%
Apr. 18 RadNet Closes Term Loan, Revolving Credit Facility Refinancing Transaction MT
Apr. 18 RadNet, Inc. Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 1,021 1,011 1,609 1,080 2,361 3,567 -
Enterprise Value (EV) 1 1,021 1,011 1,609 1,080 2,361 3,567 3,567
P/E ratio 70 x -67.5 x 65.5 x 111 x 695 x 93.1 x 63.7 x
Yield - - - - - - -
Capitalization / Revenue 0.88 x 0.94 x 1.22 x 0.76 x 1.46 x 2.03 x 1.88 x
EV / Revenue 0.88 x 0.94 x 1.22 x 0.76 x 1.46 x 2.03 x 1.88 x
EV / EBITDA 6.22 x 7.25 x 7.35 x 5.61 x 10.2 x 13.3 x 11.9 x
EV / FCF 33.8 x 7.24 x 139 x 40.1 x 53.3 x 46.4 x 38.2 x
FCF Yield 2.96% 13.8% 0.72% 2.5% 1.87% 2.16% 2.61%
Price to Book 6.73 x 6.1 x 7.04 x 3.26 x - - -
Nbr of stocks (in thousands) 50,272 51,636 53,437 57,361 67,895 73,708 -
Reference price 2 20.30 19.57 30.11 18.83 34.77 48.40 48.40
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1,154 1,072 1,315 1,430 1,617 1,755 1,894
EBITDA 1 164.1 139.5 218.9 192.5 232.3 268.6 298.9
EBIT 1 69.88 35.68 82.55 46.36 98.7 121.7 144.1
Operating Margin 6.05% 3.33% 6.28% 3.24% 6.11% 6.94% 7.61%
Earnings before Tax (EBT) 1 29.67 -0.854 58.88 42.97 38.81 85.45 110.6
Net income 1 14.76 -14.84 24.73 10.65 3.044 38.7 56.72
Net margin 1.28% -1.38% 1.88% 0.74% 0.19% 2.2% 3%
EPS 2 0.2900 -0.2900 0.4600 0.1700 0.0500 0.5200 0.7600
Free Cash Flow 1 30.17 139.6 11.62 26.97 44.26 76.89 93.27
FCF margin 2.61% 13.02% 0.88% 1.89% 2.74% 4.38% 4.93%
FCF Conversion (EBITDA) 18.38% 100.09% 5.31% 14.01% 19.05% 28.63% 31.2%
FCF Conversion (Net income) 204.45% - 46.98% 253.2% 1,454.11% 198.7% 164.43%
Dividend per Share - - - - - - -
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 332.7 333.2 341.8 354.4 350 383.9 390.6 403.7 402 420.4 421.7 438.5 434.2 460.5 459
EBITDA 1 62.28 54.51 38.13 51.34 45.77 57.23 48.16 60.44 57.92 65.81 55.29 68.66 68.19 76.43 64.5
EBIT 1 32.57 4.652 -1.719 19.56 6.924 21.6 6.671 24.44 43.25 24.34 14.29 34.71 33.25 39.48 17.87
Operating Margin 9.79% 1.4% -0.5% 5.52% 1.98% 5.63% 1.71% 6.05% 10.76% 5.79% 3.39% 7.92% 7.66% 8.57% 3.89%
Earnings before Tax (EBT) 1 26.43 3.34 9.859 17.23 8.635 7.243 -13.15 13.94 31.29 6.73 3.692 27.71 24.58 29.47 11.38
Net income 1 16.22 -3.823 3.013 7.905 0.668 -0.934 -21 8.369 17.54 -1.858 -3.744 14.47 12.24 15.74 1.772
Net margin 4.88% -1.15% 0.88% 2.23% 0.19% -0.24% -5.38% 2.07% 4.36% -0.44% -0.89% 3.3% 2.82% 3.42% 0.39%
EPS 2 0.3000 -0.0700 0.0500 0.1300 0.0100 -0.0200 -0.3600 0.1200 0.2500 -0.0300 -0.0550 0.1950 0.1650 0.2100 0.0250
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/8/21 3/1/22 5/9/22 8/9/22 11/9/22 3/1/23 5/9/23 8/8/23 11/8/23 2/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 30.2 140 11.6 27 44.3 76.9 93.3
ROE (net income / shareholders' equity) 10.6% - 12.5% 4.28% - 4.1% 5.7%
ROA (Net income/ Total Assets) 1.07% - 1.29% 0.54% - 1.5% 2.2%
Assets 1 1,377 - 1,923 1,989 - 2,580 2,578
Book Value Per Share 3.010 3.210 4.270 5.770 - - -
Cash Flow per Share - - - - - - -
Capex 1 73 93.3 138 119 177 136 155
Capex / Sales 6.32% 8.71% 10.48% 8.35% 10.92% 7.76% 8.17%
Announcement Date 3/12/20 3/8/21 3/1/22 3/1/23 2/29/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for RadNet, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
48.4 USD
Average target price
53.33 USD
Spread / Average Target
+10.19%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-15.34% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. RDNT Stock
  4. Financials RadNet, Inc.